K. A. N. Abusharkh Et Al. , "Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study," 8th International BAU-Drug Design Congress , İstanbul, Turkey, pp.76, 2022
Abusharkh, K. A. N. Et Al. 2022. Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study. 8th International BAU-Drug Design Congress , (İstanbul, Turkey), 76.
Abusharkh, K. A. N., Cömert Önder, F., Hamurcu, Z., Özpolat, B., & Ay, M., (2022). Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study . 8th International BAU-Drug Design Congress (pp.76). İstanbul, Turkey
Abusharkh, Khaled Et Al. "Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study," 8th International BAU-Drug Design Congress , İstanbul, Turkey, 2022
Abusharkh, Khaled A. Et Al. "Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study." 8th International BAU-Drug Design Congress , İstanbul, Turkey, pp.76, 2022
Abusharkh, K. A. N. Et Al. (2022) . "Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study." 8th International BAU-Drug Design Congress , İstanbul, Turkey, p.76.
@conferencepaper{conferencepaper, author={Khaled A. N. Abusharkh Et Al. }, title={Investigation of Potential Candidates as FOXM1 Inhibitors for the Treatment of Triple Negative Breast Cancer by In silico and In vitro Studies: A Drug Repurposing Study}, congress name={8th International BAU-Drug Design Congress }, city={İstanbul}, country={Turkey}, year={2022}, pages={76} }